Protection by flavanol-rich foods againstvascular dysfunction and oxidative damage: 27th Hohenheim consensus conference

Advances in Nutrition

Volumn 3, Issue 2, 2012, Pages 217-221

  Sies, Helmut ^a,b,c   Hollman, Peter C H ^d   Grune, Tilman ^e   Stahl, Wilhelm ^a   Biesalski, Hans K ^f   Williamson, Gary ^g  

^a Institute for Biochemistry and Molecular Biology I   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f UNIVERSITY OF HOHENHEIM   (Germany)

^g UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLAVONOID;

BIOAVAILABILITY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG EFFECT; FOOD; HUMAN; OXIDATIVE STRESS; VASCULAR DISEASE;

BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; FLAVONOIDS; FOOD; HUMANS; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 84866275612     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.001578     Document Type: Article

References (49)

1. Middleton E, Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells:implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52:673-751.
2. Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, Serafini M, Scalbert A, Sies H, Vidry S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr. 2011;141:989S-1009S.
3. Mladenka P, Zatloukalova L, Filipsky T, Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med. 2010;49:963-75.
4. Schroeter H, Heiss C, Spencer JP, Keen CL, Lupton JR, Schmitz HH. Recommending flavanols and procyanidins for cardiovascular health:current knowledge and future needs. Mol Aspects Med. 2010;31:546-57.
5. Scientific opinion on the substantiation of health claims related to cocoa flavanols and protection of lipids from oxidative damage, and maintenance of normal blood pressure pursuant to Article 13 (1) and Regulation (EC) No 1924/2006. EFSA J. 2011;9:2055.
6. Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J. 2011;9:2474.
7. Sies H. Polyphenols and health:update and perspectives. Arch Biochem Biophys. 2010;501:2-5.
8. Quideau S, Deffieux D, Douat-Casassus C, Pouysegu L. Plant polyphenols:chemical properties, biological activities, and synthesis. Angew Chem Int Ed Engl. 2011;50:586-621.
9. Bors W, Michel C. Chemistry of the antioxidant effect of polyphenols. Ann N Y Acad Sci. 2002;957:57-69.
10. Terao J. Dietary flavonoids as antioxidants. Forum Nutr. 2009;61:87-94.
11. Wolfe KL, Liu RH. Structure-activity relationships of flavonoids in the cellular antioxidant activity assay. J Agric Food Chem. 2008;56:8404-11.
12. Stevenson DE, Hurst RD. Polyphenolic phytochemicals-just antioxidants or much more? Cell Mol Life Sci. 2007;64:2900-16.
13. Mann GE, Bonacasa B, Ishii T, Siow RC. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease:protection afforded by dietary isoflavones. Curr Opin Pharmacol. 2009;9:139-45.
14. Neveu V, Perez-Jimenez J, Vos F, Crespy V, du CL, Mennen L, Knox C, Eisner R, Cruz J, et al. Phenol-Explorer:an online comprehensive database on polyphenol contents in foods. Database (Oxford). 2010;2010:bap024.
15. Scalbert A, Andres-Lacueva C, Arita M, Kroon P, Manach C, Urpi-Sarda M, Wishart D. Databases on food phytochemicals and their health-promoting effects. J Agric Food Chem. 2011;59:4331-48.
16. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR, Jr. Flavonoid intake and cardiovascular disease mortality:a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895-909.
17. OvaskainenML, Torronen R,Koponen JM, SinkkoH, HellstromJ,Reinivuo H, Mattila P. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr. 2008;138:562-6.
18. Pérez-Jiménez J, Fezeu L, Touvier M, Arnault N, Manach C, Hercberg S, Galan P, Scalbert A. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011;93:1220-8.
19. Cooper KA, Campos-Gimenez E, Jimenez AD, Nagy K, Donovan JL, Williamson G. Rapid reversed phase ultra-performance liquid chromatography analysis of the major cocoa polyphenols and inter-relationships of their concentrations in chocolate. J Agric Food Chem. 2007;55:2841-7.
20. Khokhar S, Magnusdottir SG. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem. 2002;50:565-70.
21. Williamson G, Dionisi F, Renouf M. Flavanols from green tea and phenolic acids from coffee:critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages. Mol Nutr Food Res. 2011;55:864-73.
22. Williamson G, Clifford MN. Colonic metabolites of berry polyphenols:the missing link to biological activity? Br J Nutr. 2010;104:Suppl 3:S48-66.
23. Holt RR, Lazarus SA, SullardsMC, Zhu QY, Schramm DD, Hammerstone JF, Fraga CG, Schmitz HH, Keen CL. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002;76:798-804.
24. Stoupi S, Williamson G, Viton F, Barron D, King LJ, Brown JE, Clifford MN. In vivo bioavailability, absorption, excretion, and pharmacokinetics of [14C]procyanidin B2 in male rats. DrugMetab Dispos. 2010;38:287-91.
25. Verhagen H, Vos E, Francl S, Heinonen M. van LH. Status of nutrition and health claims in Europe. Arch Biochem Biophys. 2010;501:6-15.
26. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151-6.
27. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA. 2003;290:1030-1.
28. Ras RT, Zock PL, Draijer R. Tea consumption enhances endothelialdependent vasodilation; a meta-analysis. PLoS ONE. 2011;6:e16974.
29. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness:methodological issues and clinical applications. Eur Heart J. 2006;27:2588-605.
30. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness:a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-27.
31. PaseMP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness:a systematic review. Am J Clin Nutr. 2011;93:446-54.
32. Dragsted LO. Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers. Eur J Nutr. 2008;47:Suppl 2:3-18.
33. Mayne ST. Antioxidant nutrients and chronic disease:use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr. 2003; 133:Suppl 3:933S-40S.
34. Grune T, Berger MM. Markers of oxidative stress in ICU clinical settings:present and future. Curr Opin Clin Nutr Metab Care. 2007;10:712-7.
35. Knasmüller S, Nersesyan A, Misik M, Gerner C, Mikulits W, Ehrlich V, Hoelzl C, Szakmary A, Wagner KH. Use of conventional and -omics based methods for health claims of dietary antioxidants:a critical overview. Br J Nutr. 2008;99 E:Suppl 1:ES3-52.
36. Loft S, Moller P, Cooke MS, Rozalski R, Olinski R. Antioxidant vitamins and cancer risk:is oxidative damage to DNA a relevant biomarker? Eur J Nutr. 2008;47:Suppl 2:19-28.
37. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52:601-23.
38. Dusinska M, Collins AR. The comet assay in human biomonitoring:gene-environment interactions. Mutagenesis. 2008;23:191-205.
39. Griffiths HR, Møller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hobert AM, et al. Biomarkers. Mol Aspects Med. 2002;23:101-208.
40. Lapointe A, Couillard C, Lemieux S. Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem. 2006;17:645-58.
41. Requena JR, Levine RL, Stadtman ER. Recent advances in the analysis of oxidized proteins. Amino Acids. 2003;25:221-6.
42. Collins AR. The use of bacterial repair endonucleases in the comet assay. Methods Mol Biol. 2011;691:137-47.
43. Griffiths HR. Antioxidants and protein oxidation. Free Radic Res. 2000; 33:Suppl:S47-58.
44. Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem. 2005;53:1841-56.
45. Bartosz G. Non-enzymatic antioxidant capacity assays:limitations of use in biomedicine. Free Radic Res. 2010;44:711-20.
46. Sies H. Total antioxidant capacity:appraisal of a concept. J Nutr. 2007; 137:1493-5.
47. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk:a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
48. Flynn A. Scientific substantiation of health claims in the EU. Proc Nutr Soc. 2011;Sep 20:1-7.
49. Biesalski HK, Aggett PJ, Anton R, Bernstein PS, Blumberg J, Heaney RP, Henry J, Nolan JM, Richardson DP, van Ommen B, et al. 26th Hohenheim Consensus Conference, September 11, 2010. Scientific substantiation of health claims:evidence-based nutrition. Nutrition. 2011;27:S1-20.